Corcept Therapeutics (CORT) Capital Expenditures (2012 - 2026)
Corcept Therapeutics (CORT) posted Capital Expenditures of $2.5 million for Q2 2026, up 1157.71% sequentially from $201000.0 in Q1 2026, and up 4335.09% YoY from $57000.0 in Q2 2025.
Corcept Therapeutics (CORT) Capital Expenditures (2012 - 2026) Analysis & Trends
Corcept Therapeutics has reported Capital Expenditures for 15 years, with the latest figure at $2.5 million in Q2 2026.
- Quarterly Capital Expenditures rose 4335.09% year-over-year to $2.5 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $2.8 million (up 44.97% YoY) and the FY2025 annual result came in at $211000.0, down 90.29% from the prior year.
- Capital Expenditures grew to $2.5 million in Q2 2026 per CORT's latest filing, from $201000.0 in the prior quarter.
- Over five years, Capital Expenditures peaked at $2.5 million in Q2 2026 and troughed at $12000.0 in Q1 2022.
- A 5-year average of $404571.4 and a median of $103000.0 in 2023 frame the typical range for Capital Expenditures.
- The sharpest annual moves came in 2022 and 2026: Capital Expenditures plunged 90.48% in 2022, then jumped 4335.09% in 2026.
- Over 5 years, Capital Expenditures stood at $31000.0 in 2022, then climbed by 19.35% to $37000.0 in 2023, then jumped by 227.03% to $121000.0 in 2024, then sank by 58.68% to $50000.0 in 2025, then soared by 4956.0% to $2.5 million in 2026.
- According to Business Quant data, Capital Expenditures over the past three periods registered $2.5 million, $201000.0, and $50000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 112.20 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 240.20 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 2.29 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 25.02 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 572,662.23 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 251.02 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 34.68 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.26 Mn |
| 10 | Corcept Therapeutics | 12.37 Bn | 12.07 Bn | 252.09 Mn | 2.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.53 Mn |
| Jun 30, 2026 | 2.53 Mn |
| Mar 31, 2026 | 201,000.00 |
| Mar 31, 2026 | 201,000.00 |
| Dec 31, 2025 | 50,000.00 |
| Dec 31, 2025 | 50,000.00 |
| Jun 30, 2025 | 57,000.00 |
| Jun 30, 2025 | 57,000.00 |
| Mar 31, 2025 | 104,000.00 |
| Mar 31, 2025 | 104,000.00 |
| Dec 31, 2024 | 121,000.00 |
| Dec 31, 2024 | 121,000.00 |
| Sep 30, 2024 | 1.64 Mn |
| Sep 30, 2024 | 1.64 Mn |
| Jun 30, 2024 | 416,000.00 |
| Jun 30, 2024 | 416,000.00 |
| Sep 30, 2023 | 37,000.00 |
| Sep 30, 2023 | 37,000.00 |
| Jun 30, 2023 | 102,000.00 |
| Jun 30, 2023 | 102,000.00 |